Singapore and Thailand have implemented comprehensive health screenings at airports and seaports to manage the spread of mpox, focusing on travelers from high-risk areas. These measures aim to protect public health and maintain the countries’ status as safe travel destinations while ensuring a smooth tourism recovery.
The World Health Organization (WHO) has approved the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, a critical step in expanding global access to accurate and timely mpox testing. The Alinity m MPXV assay, produced by Abbott Molecular Inc., is a real-time PCR test that detects monkeypox virus DNA, aiding in the rapid confirmation of suspected cases. This move is particularly significant in countries experiencing mpox outbreaks, where quick and reliable testing is crucial for effective containment.
Kerala has reported its second case of monkeypox (Mpox), with a man who recently returned from the UAE testing positive for the disease. This comes just a few weeks after the state reported its first case, raising concerns about potential community spread.
India has issued new guidelines to states and union territories, urging them to enforce strict infection prevention and control measures to curb the spread of mpox. This comes after the country confirmed its second case of the virus, bringing the total to two. The guidelines emphasize public awareness, isolation of suspected cases, building isolation facilities, symptomatic treatment, and robust diagnostic capabilities.
India has issued a national advisory on Mpox, urging states to prepare for potential outbreaks after a case of the more virulent clade 1b strain was detected. The advisory emphasizes isolation of suspected cases, strict infection control measures, and the need to strengthen public health facilities.
India has taken precautionary measures to prevent a widespread Mpox outbreak after reporting a case of the more transmissible clade 1b strain. The Union health secretary has directed states to enhance awareness, strengthen testing capabilities, and review public health preparedness.
India has reported its first case of Mpox, a viral disease caused by the monkeypox virus, in a 38-year-old man who recently returned from the United Arab Emirates. The patient was diagnosed with Mpox clade I, a less common variant of the virus. This article provides information on symptoms, transmission, treatment, and the current global outbreak of Mpox.
A 38-year-old man in Kerala has been diagnosed with Mpox, marking the latest case in the state. The patient recently returned from the UAE, highlighting the ongoing global spread of the virus. Mpox is characterized by a painful rash, swollen lymph nodes, and other flu-like symptoms.
With the first case of Monkeypox reported in India, concerns about the spread of the disease have risen. While experts emphasize the need for vigilance, they also highlight that the disease is less fatal than COVID-19 and the risk of a pandemic seems low. This article explores the symptoms, transmission, and precautions related to Monkeypox.
Applied DNA Sciences, through its subsidiary Applied DNA Clinical Labs (ADCL), has expanded its clinical testing services for mpox, leading to a 37% surge in its stock price. The new service now includes detection of both Mpox Clade I and Clade II, aiming to bolster efforts to combat the rising mpox threat.
